Emergent BioSolutions Inc. Quarterly Amortization of Intangible Assets in USD from Q1 2014 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary: Emergent BioSolutions Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2014 to Q3 2024.
Emergent BioSolutions Inc. Amortization of Intangible Assets for the quarter ending September 30, 2024 was $16.3M, unchanged year-over-year.
Emergent BioSolutions Inc. Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $65M, a 3.42% decline year-over-year.
Emergent BioSolutions Inc. annual Amortization of Intangible Assets for 2023 was $65.6M, a 9.52% increase from 2022.
Emergent BioSolutions Inc. annual Amortization of Intangible Assets for 2022 was $59.9M, a 2.39% increase from 2021.
Emergent BioSolutions Inc. annual Amortization of Intangible Assets for 2021 was $58.5M, a 2.17% decline from 2020.

Amortization of Intangible Assets, Trailing 12 Months (USD)

Amortization of Intangible Assets, Quarterly (USD)

Amortization of Intangible Assets, YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	$65M	$16.3M	$0	0%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$65M	$16.3M	+$200K	+1.24%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-07
Q1 2024	$64.8M	$16.2M	-$800K	-4.71%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-02
Q4 2023	$65.6M	$16.2M	-$1.7M	-9.5%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-08
Q3 2023	$67.3M	$16.3M	+$2.3M	+16.4%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-07
Q2 2023	$65M	$16.1M	+$2.1M	+15%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-07
Q1 2023	$62.9M	$17M	+$3M	+21.4%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-02
Q4 2022	$59.9M	$17.9M	+$3.9M	+27.9%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-08
Q3 2022	$56M	$14M	-$500K	-3.45%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-12-11
Q2 2022	$56.5M	$14M	-$1.1M	-7.29%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-09
Q1 2022	$57.6M	$14M	-$900K	-6.04%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-10
Q4 2021	$58.5M	$14M	-$1M	-6.67%	Oct 1, 2021	Dec 31, 2021	10-K	2024-03-08
Q3 2021	$59.5M	$14.5M	-$500K	-3.33%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-09
Q2 2021	$60M	$15.1M	+$100K	+0.67%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-02
Q1 2021	$59.9M	$14.9M	+$100K	+0.68%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-04-29
Q4 2020	$59.8M	$15M	+$200K	+1.35%	Oct 1, 2020	Dec 31, 2020	10-K/A	2023-12-11
Q3 2020	$59.6M	$15M	+$300K	+2.04%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-05
Q2 2020	$59.3M	$15M	+$300K	+2.04%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-07-30
Q1 2020	$59M	$14.8M	+$300K	+2.07%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-04-30
Q4 2019	$58.7M	$14.8M	+$1.5M	+11.3%	Oct 1, 2019	Dec 31, 2019	10-K	2022-02-25
Q3 2019	$57.2M	$14.7M	+$10.8M	+277%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-06
Q2 2019	$46.4M	$14.7M	+$10.8M	+277%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-07-31
Q1 2019	$35.6M	$14.5M	+$10.6M	+272%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-01
Q4 2018	$25M	$13.3M	+$9.45M	+246%	Oct 1, 2018	Dec 31, 2018	10-K	2021-02-19
Q3 2018	$15.5M	$3.9M	+$2.3M	+144%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-07
Q2 2018	$13.2M	$3.9M	+$2.3M	+144%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-02
Q1 2018	$10.9M	$3.9M	+$2.35M	+151%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-08
Q4 2017	$8.6M	$3.85M	+$2.18M	+131%	Oct 1, 2017	Dec 31, 2017	10-K	2020-02-25
Q3 2017	$6.42M	$1.6M	-$51K	-3.09%	Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-02
Q2 2017	$6.47M	$1.6M	-$243K	-13.2%	Apr 1, 2017	Jun 30, 2017	10-Q	2018-08-03
Q1 2017	$6.71M	$1.55M	-$289K	-15.7%	Jan 1, 2017	Mar 31, 2017	10-Q	2018-05-04
Q4 2016	$7M	$1.66M	+$665K	+66.6%	Oct 1, 2016	Dec 31, 2016	10-K	2019-02-22
Q3 2016	$6.34M	$1.65M	-$193K	-10.5%	Jul 1, 2016	Sep 30, 2016	10-Q	2017-11-03
Q2 2016	$6.53M	$1.84M	-$549K	-23%	Apr 1, 2016	Jun 30, 2016	10-Q	2017-08-04
Q1 2016	$7.08M	$1.84M	-$299K	-14%	Jan 1, 2016	Mar 31, 2016	10-Q	2017-05-05
Q4 2015	$7.38M	$998K	-$3.17M	-76%	Oct 1, 2015	Dec 31, 2015	10-K	2018-02-23
Q3 2015	$10.5M	$1.84M	-$371K	-16.7%	Jul 1, 2015	Sep 30, 2015	10-Q	2016-11-09
Q2 2015	$10.9M	$2.39M	+$143K	+6.36%	Apr 1, 2015	Jun 30, 2015	10-Q	2016-08-05
Q1 2015	$10.8M	$2.14M	+$3.78M		Jan 1, 2015	Mar 31, 2015	10-Q	2016-05-06
Q4 2014	$6.99M	$4.16M			Oct 1, 2014	Dec 31, 2014	10-K	2017-02-28
Q3 2014		$2.22M			Jul 1, 2014	Sep 30, 2014	10-Q	2015-11-06
Q2 2014		$2.25M			Apr 1, 2014	Jun 30, 2014	10-Q	2015-08-06
Q1 2014		-$1.64M			Jan 1, 2014	Mar 31, 2014	10-Q	2015-05-08

* An asterisk sign (*) next to the value indicates that the value is likely invalid.